Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
43.4M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
9.57M
-
Shares change
-
+9.57M
-
Total reported value, excl. options
-
$200M
-
Value change
-
+$200M
-
Number of buys
-
49
-
Price
-
$20.89
Significant Holders of SI-BONE, Inc. - Common Stock, $0.001 par value (SIBN) as of Q4 2018
49 filings reported holding SIBN - SI-BONE, Inc. - Common Stock, $0.001 par value as of Q4 2018.
SI-BONE, Inc. - Common Stock, $0.001 par value (SIBN) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.57M shares
of 43.4M outstanding shares and own 22.05% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (985K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (967K shares), Novo Holdings A/S (893K shares), RTW INVESTMENTS, LP (804K shares), BlackRock Inc. (758K shares), PRICE T ROWE ASSOCIATES INC /MD/ (748K shares), Redmile Group, LLC (641K shares), WELLS FARGO & COMPANY/MN (431K shares), GILDER GAGNON HOWE & CO LLC (356K shares), and PEREGRINE CAPITAL MANAGEMENT LLC (321K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.